Related Experiment Video
Updated: May 10, 2026
10:24
Non-destructive SPE-UPLC-based Quantification of Aflatoxins and Stilbenoid Phytoalexins in Single Peanut (Arachis spp.) Seeds
Published on: April 19, 2024
Genotoxicological Evaluation of NUTRALYS Pea Protein Isolate
Chentouf Aouatif1, Ph Looten, M V S Parvathi
1Biology and Nutrition Department, Roquette Frères, 62136 Lestrem, France.
ISRN Toxicology
|June 14, 2013
Summary
NUTRALYS Pea Protein Isolate demonstrated no genotoxic potential in bacterial reverse mutation, chromosomal aberration, and micronucleus tests. This protein supplement is safe for use, showing no adverse effects in standard genotoxicity assays.
Area of Science:
- Food Science
- Toxicology
- Biochemistry
Background:
- NUTRALYS Pea Protein Isolate is a functional protein derived from yellow peas, known for its emulsifying properties.
- Evaluating the genotoxic potential of food ingredients is crucial for ensuring consumer safety.
Purpose of the Study:
- To assess the genotoxic potential of NUTRALYS Pea Protein Isolate using internationally recognized guidelines.
- To determine if NUTRALYS exhibits mutagenic or clastogenic effects.
Main Methods:
- The study employed three standard genotoxicity tests: the Ames test (bacterial reverse mutation), the in vitro chromosomal aberration test, and the in vivo micronucleus test.
- All tests were conducted according to OECD guidelines under Good Laboratory Practice (GLP) conditions.
Main Results:
- NUTRALYS did not induce mutations in the Ames test across various bacterial strains.
- No chromosomal aberrations were observed in the in vitro test, with or without metabolic activation.
- The in vivo micronucleus test showed no significant increase in micronucleated erythrocytes, indicating no clastogenic effect.
Conclusions:
- NUTRALYS Pea Protein Isolate does not possess genotoxic potential.
- The findings support the safety of NUTRALYS Pea Protein Isolate as a food ingredient.
Related Concept Videos
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.